Theory Paper IIIDrNB Cardiology – Theory Notes
CORONARY INTRAVASCULAR LITHOTRIPSY (IVL)
ITHE BIOPHYSICAL MECHANISM (SONIC ACOUSTIC WAVEFRONT)
- Technology: Adapted from urological extracorporeal shockwave lithotripsy; the Shockwave C2+ Coronary IVL catheter is a rapid-exchange semi-compliant angioplasty balloon (2.5 to 4.0 mm diameters, 12 mm length) containing two radiopaque electrohydraulic lithotripsy emitters connected to an external pulse generator.
- Mechanism of Action: The IVL balloon is inflated gently to 4 atmospheres (solely to achieve fluid-coupled apposition with the arterial wall without barotrauma), and electrical discharge across the emitters vaporizes the 50:50 saline-contrast mixture inside the balloon, creating a rapidly expanding and collapsing cavitation vapor bubble. This generates unfocused, circumferential sonic acoustic pressure waves (1 pulse per second; 10 pulses per cycle; up to 80 to 120 pulses per catheter) with a peak positive pressure equivalent to ~50 atmospheres.
- Selective Calcium Fracture: Acoustic waves pass harmlessly through soft elastic vascular tissue (which has the same acoustic impedance as water) while imparting compressive and shear stress on high-acoustic-impedance superficial intimal and deep medial calcium, creating multi-plane longitudinal and circumferential micro- and macro-fractures that restore vessel compliance and enable full stent expansion at low pressures.
IICLINICAL INDICATIONS FOR CORONARY IVL
- Severely Calcified De Novo Lesions: Indicated when OCT or IVUS identifies a high calcium burden—specifically an OCT Calcium Score of 4 (calcium arc greater than 180 degrees, thickness greater than 0.5 mm, and length greater than 5.0 mm) or a superficial IVUS calcium arc greater than 270 to 360 degrees.
- Deep Medial and Eccentric/Nodular Calcification: Uniquely effective for deep medial calcium (separated from the lumen by fibrous tissue) that superficial rotational/orbital atherectomy burrs cannot reach, as well as concentric (360-degree) and eccentric/nodular calcium.
- Large-Vessel and Bifurcation Calcification (e.g., Distal Left Main): Ideal for large-caliber vessels (3.5 to 4.0+ mm) where a 1.5–1.75 mm rotational burr has an inadequate burr-to-artery ratio, and for calcified bifurcations because a side-branch protection wire can remain safely in place during lithotripsy.
- Refractory Stent Under-Expansion / Calcified In-Stent Restenosis (Off-Label High-Value Niche): Safely fractures thick circumferential calcium behind the struts of a previously deployed, under-expanded metallic stent where high-speed atherectomy burrs carry high risks of burr entrapment and strut avulsion.
IIIADVANTAGES OF IVL OVER ROTATIONAL ATHERECTOMY (ROTABLATION)
| Technical / Clinical Feature | Coronary Intravascular Lithotripsy (IVL) | Rotational Atherectomy (Rotablator) |
|---|---|---|
| Mechanism of Action | Disruptive: Sonic acoustic pressure waves (~50 atm) fracture calcium in situ | Ablative: High-speed (140–160k RPM) diamond burr sands superficial calcium into microparticles |
| Depth of Calcium Modification | Both superficial intimal AND deep medial calcium | Superficial (luminal) calcium only |
| Slow-Flow / No-Reflow Risk | Extremely Low (<0.5%) — fractured calcium stays inside the vessel wall | Higher (2% to 5%) — embolic microparticle debris & platelet activation |
| Guidewire & Side-Branch Wire | Uses any standard 0.014-inch workhorse wire; safe to keep a jailed side-branch wire | Requires dedicated 0.009-inch RotaWire; side-branch wire must be removed (burr severs wire) |
| Perforation & Dissection Rate | Very Low (<0.5%) — low 4-atm balloon inflation | Higher risk in angulated/eccentric vessels (~1–2%) |
| Uncrossable Pinhole Lesions | Cannot cross until a channel is created (crossing profile ~0.044–0.047 inch) | Gold Standard for balloon-uncrossable pinhole stenoses |
IVLIMITATIONS AND PROCEDURAL CONSIDERATIONS
- Crossability Limitation: Because the IVL catheter is a relatively bulky balloon platform (crossing profile 0.044 to 0.047 inches, requiring a 6F guide catheter), it cannot cross severe “balloon-uncrossable” pinhole calcified stenoses without prior predilation with a small low-profile balloon or initial rotational/orbital atherectomy (“RotaTripsy”).
- “Shocktopics” (Ventricular Ectopy / Pacing Capture): Acoustic pulses can mechanically depolarize the myocardium (mechano-electrical coupling), producing benign ventricular ectopy or transient pacing capture in ~40 percent of cases (with zero sustained VT/VF reported in DISRUPT CAD when heart rate is >60 bpm).
- Balloon Rupture and Cost: Sharp calcium spicules can occasionally pinhole-rupture the IVL balloon, and single-use IVL catheters carry a substantially higher device cost than standard balloons or rotational burrs.
VLANDMARK EVIDENCE AND CURRENT STATUS
- DISRUPT CAD I, II, III, and IV Trials (Pooled Analysis, Kereiakes et al., JACC Cardiovasc Interv 2021): Across 628 patients with severely calcified lesions in 4 prospective studies, IVL achieved 92.4 percent primary procedural success, 99.5 percent freedom from 30-day perforation, abrupt closure, or no-reflow, and an OCT-confirmed minimum stent area of 6.5 mm2 (>100% stent expansion) with multi-plane calcium fractures.
- The “RotaTripsy” Hybrid Standard: In severe balloon-uncrossable AND deep thick circumferential calcified lesions, contemporary practice combines front-end Rotational Atherectomy (using a small 1.25 or 1.5 mm burr to create a lumen channel) followed immediately by IVL (sized 1:1 to the reference vessel) to fracture the deep medial calcium ring.
Key references
- Hill JM, Kereiakes DJ, Shlofmitz RA, et al. (DISRUPT CAD III Investigators): Intravascular lithotripsy for treatment of severely calcified coronary artery disease, Journal of the American College of Cardiology, 2020.
- Kereiakes DJ, Di Mario C, Riley RF, et al.: Intravascular Lithotripsy for Treatment of Calcified Coronary Lesions: Patient-Level Pooled Analysis of the Disrupt CAD Studies, JACC: Cardiovascular Interventions, 2021.
- Riley RF, Patel MP, Abbott JD, et al.: SCAI Expert Consensus Statement on the Management of Calcified Coronary Lesions, JSCAI, 2024.
meritmedscript.comDr. Sidhartha Mullapudi
